Towa Pharmaceutical Co., Ltd. (TYO:4553)

Japan flag Japan · Delayed Price · Currency is JPY
3,720.00
-70.00 (-1.85%)
Feb 13, 2026, 3:30 PM JST
Market Cap183.13B +21.2%
Revenue (ttm)266.67B +9.3%
Net Income20.65B +30.9%
EPS419.38 +30.9%
Shares Out49.23M
PE Ratio8.87
Forward PE9.90
Dividend80.00 (2.11%)
Ex-Dividend DateMar 30, 2026
Volume113,400
Average Volume97,760
Open3,800.00
Previous Close3,790.00
Day's Range3,705.00 - 3,810.00
52-Week Range2,298.00 - 3,810.00
Beta-0.30
RSI58.26
Earnings DateFeb 13, 2026

About Towa Pharmaceutical

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. It operates through two segments; Domestic and Overseas. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from Tablets, Capsules, Injectable, Patches, eye drops, and other products. It also offers IT service related to healthcare; disease risk testing services; and quasi drugs. In ... [Read more]

Sector Healthcare
Founded 1951
Employees 4,788
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4553
Full Company Profile

Financial Performance

In fiscal year 2025, Towa Pharmaceutical's revenue was 259.59 billion, an increase of 13.89% compared to the previous year's 227.93 billion. Earnings were 18.99 billion, an increase of 17.39%.

Financial Statements